JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis

被引：56
|
作者：
Regina, S.
Herault, O.
D'Alteroche, L.
Binet, C.
Gruel, Y.
机构：
[1] Trousseau Hosp, Dept Haematol Haemostasis, Tours, France
[2] Trousseau Hosp, INSERM, U618, Tours, France
[3] Univ Tours, Tours, France
[4] Bretonneau Hosp, Haematol Lab, Tours, France
[5] Bretonneau Hosp, INSERM, ESPRI EA3855, Tours, France
[6] Trousseau Hosp, Dept Gastroenterol & Hepatol, Tours, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1111/j.1538-7836.2007.02384.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 861
页数：3
相关论文
共 50 条
  • [1] The JAK2 mutation V617F is specifically associated with idiopathic splanchnic vein thrombosis.
    Regina, Sandra
    Herault, Olivier
    D'alteroche, Louis
    Bacq, Yannick
    Domenenech, Jorge
    Binet, Christian
    Gruel, Yves
    BLOOD, 2006, 108 (11) : 117A - 117A
  • [2] JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis
    De Stefano, Valerio
    Rossi, Elena
    Za, Tommaso
    Ciminello, Angela
    Betti, Silvia
    Luzzi, Claudia
    Leone, Giuseppe
    Chiusolo, Patrizia
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (06) : 526 - 528
  • [3] JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein Thrombosis
    Amandeep Salhotra
    Thein H. Oo
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 4 - 8
  • [4] JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein Thrombosis
    Salhotra, Amandeep
    Oo, Thein H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 : S4 - S8
  • [5] The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis
    Goodyer, Matthew
    Langabeer, Stephen E.
    Haslam, Karl
    Murphy, Karen
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 229 - 230
  • [6] V617F mutation in JAK2 is associated idiopathic myelofibrosis
    Campbell, PJ
    Griesshammer, M
    Döhner, K
    Döhner, H
    Kusec, R
    Hasselbalch, HC
    Larsen, TS
    Pallisgaard, N
    Giraudier, S
    Le Bousse-Kerdilès, MC
    Desterke, C
    Guerton, B
    Dupriez, B
    Bordessoule, D
    Fenaux, P
    Kiladjian, JJ
    Viallard, JF
    Brière, J
    Harrison, CN
    Green, AR
    Reilly, JT
    BLOOD, 2006, 107 (05) : 2098 - 2100
  • [7] Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis
    Yoo, E. -H.
    Jang, J. -H.
    Park, K. -J.
    Gwak, G. -Y.
    Kim, H. -J.
    Kim, S. -H.
    Kim, D. -K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 471 - 476
  • [8] MASKED MYELOPROLIFERATIVE DISORDERS AND JAK2 (V617F) DETECTION IN SPLANCHNIC VEIN THROMBOSIS: A SINGLE CENTER EXPERIENCE
    Rago, A.
    Fama, A.
    Marzano, C.
    Mammi, C.
    Lagana, C.
    Bizzoni, L.
    D'Elia, G. M.
    Ribersani, M.
    Gioiosa, F.
    Natalino, F.
    Breccia, M.
    Carmosino, I
    Latagliata, R.
    Foa, R.
    Alimena, G.
    Riggio, O.
    Tafuri, A.
    HAEMATOLOGICA, 2008, 93 : S70 - S70
  • [9] Causal role for JAK2 V617F in thrombosis
    Fleischman, Angela G.
    Tyner, Jeffrey W.
    BLOOD, 2013, 122 (23) : 3705 - 3706
  • [10] JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders
    Owens, Christopher D.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (01) : 205 - 207
12345